| # | Drug | Count |
|---|---|---|
| 0 | RALTEGRAVIR | 41 |
| 1 | RITONAVIR | 32 |
| 2 | DARUNAVIR | 31 |
| 3 | ETRAVIRINE | 31 |
| 4 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 30 |
| 5 | ZIDOVUDINE | 30 |
| 6 | METHOTREXATE SODIUM | 17 |
| 7 | METHOTREXATE | 16 |
| 8 | PREDNISOLONE | 14 |
| 9 | PREDNISOLONE ORAL | 14 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MINOXIDIL 2% | 1 | 0.0370 |
| 1 | RALTEGRAVIR | 41 | 0.0078 |
| 2 | ETRAVIRINE | 31 | 0.0070 |
| 3 | NITROUS OXIDE | 10 | 0.0045 |
| 4 | ZIDOVUDINE | 30 | 0.0029 |
| 5 | DARUNAVIR | 31 | 0.0020 |
| 6 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 10 | 0.0016 |
| 7 | PENICILLIN G POTASSIUM | 1 | 0.0014 |
| 8 | DARUNAVIR 600 MG | 7 | 0.0011 |
| 9 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 30 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 31 | 0.0013 |
| 1 | Protease Inhibitor [EPC] | 34 | 0.0008 |
| 2 | Cytochrome P450 3A Inhibitor [EPC] | 35 | 0.0006 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 46 | 0.0004 |
| 4 | Oxytocic [EPC] | 1 | 0.0003 |
| 5 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 11 | 0.0002 |
| 6 | Antirheumatic Agent [EPC] | 13 | 0.0001 |
| 7 | Interleukin-6 Receptor Antagonist [EPC] | 13 | 0.0001 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 8 | 0.0001 |
| 9 | Erythropoiesis-stimulating Agent [EPC] | 4 | 0.0001 |